Don't miss the 2nd #CIOMS webinar on #AI in PV. This edition is scheduled for audiences in the Asia-Pacific region and features UMC's Niklas Norén and expert panellists:

📆 Thursday, 26 March
🕣 08:30–10:00 IST / 20:00–21:30 PDT
📍 Online

Register today 👉 https://ow.ly/5XSK50Ywazh

UMC's Niklas Norén will discuss the #CIOMS WG XIV report on #AI in PV and the chapters on validity/robustness and transparency. The webinar also features an expert panel discussion:

📆 Friday, 6 March
🕑 14:00–15:30 CET
📍 Online

Spaces are limited. Register today 👉 https://ow.ly/X4FY50YnSCp

CIOMS Cumulative Glossary, with a focus on Pharmacovigilance (Version 2.3) • COUNCIL FOR INTERNATIONAL ORGANIZATIONS OF MEDICAL SCIENCES This glossary compiles the terms and definitions from published CIOMS reports, with a focus on pharmacovigilance. We welcome all feedback. Please e-mail your recommendations to info@cioms.ch.

📖 Looking for a glossary of #pharmacovigilance terms and definitions?

Version 2.4 of the #CIOMS Cumulative Glossary compiles all terms and definitions included in WG reports on pharmacovigilance. New to this edition is the inclusion of terms on #AI in PV👇

Glossary of ICH terms and definitions • COUNCIL FOR INTERNATIONAL ORGANIZATIONS OF MEDICAL SCIENCES Version 9, 9th December 2025 -- This glossary combines the terms and definitions included in the guidelines of the International Council for Harmonisation

📚 New release – Version 9 of the #CIOMS Glossary of ICH Terms and definitions is now available. The glossary includes terms & definitions in the guidelines of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.

Download your copy below👇

Artificial Intelligence in Pharmacovigilance • COUNCIL FOR INTERNATIONAL ORGANIZATIONS OF MEDICAL SCIENCES This report on Artificial intelligence in pharmacovigilance addresses a rapidly emerging cross-disciplinary field that is at the intersection of

📚 New CIOMS publication: Artificial Intelligence in #Pharmacovigilance

The #CIOMS Working Group XIV report on #AI in PV proposes a framework of principles and best practices for integrating and implementing AI systems into PV activities. Access it at the link below👇

CIOMS Benefit-risk balance webinar • COUNCIL FOR INTERNATIONAL ORGANIZATIONS OF MEDICAL SCIENCES

Join #CIOMS for a webinar that introduces and explains the main concepts of the CIOMS report on Benefit-risk balance for medicinal products:

📆 Wednesday, 10 September 2025
🕑 14:00 CEST
🌐 Online

Register to attend via the link below👇

Working Group XIV - Artificial Intelligence in Pharmacovigilance • COUNCIL FOR INTERNATIONAL ORGANIZATIONS OF MEDICAL SCIENCES The first meeting held in Geneva in May 2022 was a hybrid of in-person and virtual meeting, only those physically present are seen above. Background Since

The #CIOMS Working Group XIV aims to establish and promote guidance for the use of #AI in #pharmacovigilance. A new draft report is now open for public consultation.

❗️Submit comments by 6 June

Access the draft report and learn more at the link below👇

Real‐World Data and Real‐World Evidence in Regulatory Decision Making: Report Summary From the Council for International Organizations of Medical Sciences (CIOMS) Working Group XIII Data from sources other than traditional randomized clinical trials are known as real-world data (RWD), and the evidence derived from the review and analysis of RWD is known as real-world evidence (R...

New high-level summary report from #CIOMS 📚

The report provides a summary of the findings from the CIOMS working group and describes the use of #RealWorldData and real-world evidence for regulatory decision making.

#OpenAccess via the link below👇
onlinelibrary.wiley.com/doi/10.1002/...

Severe cutaneous adverse reactions (SCAR) • COUNCIL FOR INTERNATIONAL ORGANIZATIONS OF MEDICAL SCIENCES In clinical practice, there is mounting concern in relation to the burden of SCAR in relation to novel biologics as well as the increasing cost of

In clinical practice, there is mounting concern about the burden of severe #cutaneous adverse reactions (SCAR). This #CIOMS consensus report provides insights and latest thinking on this important topic in #medicine and #pharmacovigilance
cioms.ch/publications...

Read the latest news in global health and drug safety with the #CIOMS March Newsletter !
Full issue here: ow.ly/L2au50VusQH

#GlobalHealth #CIOMS #MedicalResearch

#CIOMS: Updated Glossary of #ICH terms and definitions now available
cioms.ch/publications...